Cardium correspondingly distinguished its approach into the treatment in regard to circular stimulant disease from competitive techniques such since those stuff utilized in correspondence to corautus Genetics, which has a trio agreement by dint of Boston scientific. . . Click link for more info. (OTCBB: cdtp) announced winsome special favor decisions over Arch Development Corporation and arch’s licensee, Boston religiously exact corporation, in business conducted in the United States and in europe. Cardium therapeutics, inc. .